University of Copenhagen Hospital, Copenhagen, Denmark
Researchers' work from Denmark, Italy and Japan adds to heart attack body of knowledge
Published in Telemedicine Week, September 12th, 2006
Study 1: Additional stem cell therapy after myocardial infarction becomes optimal after three weeks.
Investigators in Denmark conducted a study "to investigate the spontaneous occurrence of circulating mesenchymal stem cells (MSC) and angiogenic factors in patients with ST elevation acute myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). In 20 patients with STEMI, blood samples were obtained on days 1, 3, 7, 14, 21, and 28 after the acute PCI."
"Fifteen patients with a normal coronary angiography formed a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week
Source: Telemedicine Week (2006-09-12)
More Articles from Telemedicine Week
- Acusphere
Acusphere reports loss of $0.84 per share - Adrenal Myelolipoma
Adrenal myelolipoma case study presented - Stanford University, U.S.
After laparoscopic gastric bypass, intraoperative fluid volume affects nausea and vomiting - Trakya University, Turkey
Alveolo-capillary permeability evaluation in diabetes improved using aerosol scintigraphy - Aachen University of Technology, Germany
Radiation exposure in low-dose multislice heart CT is predicted with calculation program - Aberdeen Maternity Hospital, Aberdeen, U.K.
Pain management with intraoperative instillation of bupivacaine shows promise - More from this issue of Telemedicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
